Aprea Therapeutics Inc (APRE) support and resistance · $10.4M cap
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
This page maps Aprea Therapeutics Inc (APRE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
APRE income-statement cache is thin, so levels here lean on the stock page until the next filing lands.
APRE currently screens at market cap $10.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new APRE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the APRE quote page for the session range and the stock page for the full model.
Not investment advice.